Logo

New Products: Natera's Panorama; GPS's CardioGene Set

Dec 18, 2013
Premium

Hong Kong-based molecular diagnostic company DiagCor is now offering Natera's Panorama test for noninvasive detection of fetal aneuploidies. The test screens for trisomy 21, trisomy 18, trisomy 13, monosomy X, triploidy, and sex chromosome aneuploidies.

The Genomics and Pathology Services Laboratory at Washington University in St. Louis has launched CardioGene Set, a 69-gene next-generation sequencing-based test that screens for cardiomyopathies and arrhythmias.

Filed under

Clinical Sequencing
Sequencing
Diagnostics
Next-Generation Sequencing
Natera
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.